Seminars in Diagnostic Pathology
Volume 24, Issue 1 , Pages 48-57 , February 2007

The neuropathology of acquired pre- and perinatal brain injuries

  • Rebecca D. Folkerth, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Rebecca D. Folkerth, MD, BWH Pathology, 75 Francis Street, Boston, MA 02115.

References 

  1. Volpe JJ. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics. 2003;112:176–180
  2. Folkerth RD. Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol. 2006;9:3–13
  3. Kinney HC. The near-term (late preterm) human brain and risk for periventricular leukomalacia: a review. Semin Perinatol. 2006;30:81–88
  4. Folkerth RD, Kinney HC. Perinatal neuropathology. In:  Love S,  Louis DN,  Ellison D editor. Greenfield’s Neuropathology. (ed 8). London: Hodder Arnold; 2007;(in press)
  5. Raju TN, Higgins RD, Stark AR, et al. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118:1207–1214
  6. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res. 2001;50:553–562
  7. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452–457
  8. Redline RW, O’Riordan MA. Placental lesions associated with cerebral palsy and neurologic impairment following term birth. Arch Pathol Lab Med. 2000;124:1785–1791
  9. Redline RW, Wilson-Costello D, Borawski E, et al. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants. Arch Pathol Lab Med. 1998;122:1091–1098
  10. Billiards SS, Pierson CR, Haynes RL, et al. Is the late preterm infant more vulnerable to gray matter injury than the term infant?. Clin Perinatol. 2006;33:915–933
  11. Kinney HC, Panigrahy A, Newburger JW, et al. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Acta Neuropathol (Berl). 2005;110:563–578
  12. Volpe JJ. Neurology of the newborn. Philadelphia, PA: WB Saunders; 1995;
  13. Inder TE, Warfield SK, Wang H, et al. Abnormal cerebral structure is present at term in premature infants. Pediatrics. 2005;115:286–294
  14. Pierson CR, Folkerth RD, Haynes RL, et al. Gray matter injury in premature infants with or without periventricular leukomalacia (PVL) (Abstract). Brain Pathol. 2006;16(suppl 1):S587
  15. Valdes-Dapena M, Huff D. Perinatal Autopsy Manual. Washington DC: Armed Forces Institute of Pathology; 1983;
  16. Kinney HC, Brody BA, Kloman AS, et al. Sequence of central nervous system myelination in human infancy (II. Patterns of myelination in autopsied infants). J Neuropathol Exp Neurol. 1988;47:217–234
  17. Talos DM, Fishman RE, Park H, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury (I. Rodent cerebral white matter and cortex). J Comp Neurol. 2006;497:42–60
  18. Talos DM, Follett PL, Folkerth RD, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury (II. Human cerebral white matter and cortex). J Comp Neurol. 2006;497:61–77
  19. Folkerth RD, Haynes RL, Borenstein NS, et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol. 2004;63:990–999
  20. Takashima S, Kuruta H, Mito T, et al. Immunohistochemistry of superoxide dismutase-1 in developing human brain. Brain Dev. 1990;12:211–213
  21. Nishida A, Misaki Y, Kuruta H, et al. Developmental expression of copper, zinc-superoxide dismutase in human brain by chemiluminescence. Brain Dev. 1994;16:40–43
  22. Ohyu J, Takashima S. Developmental characteristics of neuronal nitric oxide synthase (nNOS) immunoreactive neurons in fetal to adolescent human brains. Brain Res Dev Brain Res. 1998;110:193–202
  23. Ferriero DM, Arcavi LJ, Sagar SM, et al. Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia. Ann Neurol. 1988;24:670–676
  24. Inder TE, Huppi PS, Zientara GP, et al. The postmigrational development of polymicrogyria documented by magnetic resonance imaging from 31 weeks’ postconceptional age. Ann Neurol. 1999;45:798–801
  25. Folkerth RD. Congenital malformations, perinatal diseases, and phacomatoses. In:  Prayson RA editors. Neuropathology. Philadelphia, PA: Elsevier; 2005;p. 95–180
  26. Gilles FH, Murphy SF. Perinatal telencephalic leucoencephalopathy. J Neurol Neurosurg Psychiatry. 1969;32:404–413
  27. Folkerth RD. Neuropathologic substrate of cerebral palsy. J Child Neurol. 2005;20:940–949
  28. Armstrong DL, Sauls CD, Goddard-Finegold J. Neuropathologic findings in short-term survivors of intraventricular haemorrhage. Am J Dis Child. 1987;141:617–621
  29. Volpe JJ. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics. 2005;116:221–225
  30. Kinney HC, Haynes RL, Folkerth RD. White matter disorders in the perinatal period. In:  Golden JA,  Harding BN editor. Pathology and Genetics: Acquired and Inherited Diseases of the Developing Nervous System. Basel: ISN Neuropathology Press; 2004;p. 29–40

PII: S0740-2570(07)00030-5

doi: 10.1053/j.semdp.2007.02.006

Seminars in Diagnostic Pathology
Volume 24, Issue 1 , Pages 48-57 , February 2007

Article Tools

* Image Usage & Resolution